UNIVERSITY OF CALIFORNIA, SAN DIEGO
SAN DIEGO, California
Total Received
$394.7M
Total Awards
128
State
California
Last Updated
Mar 20, 2026
Yearly Funding Trend
$356.2M24
$35.7M25
$2.8M26
Top 50 Awards to UNIVERSITY OF CALIFORNIA, SAN DIEGO
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P30CA030199_075 ADMINISTRATIVE SUPPLEMENT TO CANCER CENTER SUPPORT GRANT (CCSG) - PROJECT SUMMARY EARLY-ONSET BREAST CANCER (EOBC), DIAGNOSED IN ADULTS AGED 18-49, EXHIBITS ALARMING INCIDENCE INC… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | LA JOLLA, CA-50 | 2024 | $73,232,839 |
ASST_NON_P01HL131474_075 PROTEIN GLYCOSYLATION IN THE COAGULOPATHY AND INFLAMMATION OF SEPSIS - SUMMARY SEPSIS IS LIFE-THREATENING SYNDROME CAUSED BY THE PRESENCE OF HARMFUL MICROORGANISMS IN THE BLOOD AN… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $26,196,066 |
ASST_NON_P01AG073084_075 AGING AS A RISK FACTOR AND TARGET FOR PREVENTION OF LIVER CANCER - PROJECT SUMMARY – OVERALL THE INCIDENCES OF LIVER CANCER (PRIMARILY HEPATOCELLULAR CARCINOMA (HCC)) ARE INCREASI… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | LA JOLLA, CA-50 | 2024 | $12,828,172 |
ASST_NON_U01DA051077_075 CLINICAL DEVELOPMENT OF AN MGLU2 POSITIVE ALLOSTERIC MODULATOR TO TREAT NICOTINE ADDICTION - PROJECT SUMMARY THIS APPLICATION ENTITLED “CLINICAL DEVELOPMENT OF AN MGLU2 POSITIVE A… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | CA-90 | 2024 | $11,417,880 |
ASST_NON_U54AG079758_075 SPATIAL MAPPING SENESCENT CELLS ACROSS THE MOUSE LIFESPAN BY MULTIPLEX TRANSCRIPTOMICS AND EPIGENOMICS - PROJECT SUMMARY CELLULAR SENESCENCE, CHARACTERIZED BY STABLE PROLIFERATION… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | CA-90 | 2024 | $10,836,434 |
ASST_NON_U01DA057847_075 SAFETY/TOXICOLOGY, ADME AND CMC ACTIVITIES TO SUPPORT THE ASSESSMENT OF THE MGLU2 PAM SBP-9330 IN A PHASE 2 CLINICAL STUDY IN SMOKERS - PROJECT SUMMARY THIS RESUBMISSION APPLICATI… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | LA JOLLA, CA-50 | 2024 | $9,048,057 |
ASST_NON_R01HL054732_075 GENETIC CONTROL OF CARDIAC DEVELOPMENT: CONGENITAL HEART DISEASE GENE DISCOVERY IN DROSOPHILA - PROJECT SUMMARY CONGENITAL HEART DEFECTS/DISEASES (CHDS) ARE THE MOST COMMON DEVEL… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CA-90 | 2024 | $8,591,478 |
ASST_NON_R35CA197465_075 REWIRED SIGNALING AT THE NEXUS OF MELANOMA METASTASIS AND RESISTANCE - DESCRIPTION (PROVIDED BY APPLICANT): MALIGNANT CELLS ARE CONTINUOUSLY EXPOSED TO EXTRINSIC (HYPOXIA, LI… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $7,901,079 |
ASST_NON_R01DK048247_075 GLYCOSYLTRANSFERASE FUNCTION IN DEVELOPMENT AND DISEASE - SUMMARY GLYCOSYLTRANSFERASES GENERATE COVALENT GLYCOSIDIC LINKAGES THAT INCLUDE POST-TRANSLATIONAL MODIFICATIONS TO THE V… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | LA JOLLA, CA-50 | 2024 | $7,405,894 |
ASST_NON_R01AR056712_075 PATHOGENIC ALTERATIONS OF THE 3D EPIGENETIC LANDSCAPE IN DYSTROPHIN-DEFICIENT SKELETAL MUSCLES AND REVERSAL BY DYSTROPHIN RE-EXPRESSION - PROJECT SUMMARY LACK OF DYSTROPHIN (DYS)… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $6,763,507 |
ASST_NON_R01DA057120_075 CHARACTERIZATION, OPTIMIZATION, AND DEVELOPMENT OF DUAL MGLU2/3 POSITIVE ALLOSTERIC MODULATORS FOR OPIOID USE DISORDER - PROJECT SUMMARY OPIOID USE DISORDER (OUD) IS A SIGNIFICANT… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | CA-90 | 2025 | $6,445,203 |
ASST_NON_UH3DA050316_075 DEVELOPMENT OF SBI-553, AN ALLOSTERIC MODULATOR OF NTR1, FOR THE TREATMENT OF SUBSTANCE USE DISORDERS - PROJECT SUMMARY OPIOID USE DISORDER (OUD) IS A MAJOR PUBLIC HEALTH CRISIS I… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | CA-90 | 2024 | $6,363,247 |
ASST_NON_R01DK099551_075 NEW CONGENITAL DISORDERS OF GLYCOSYLATION: THERAPY AND MODELS - PROJECT SUMMARY AIM1 STUDIES HOW A THERAPEUTIC SUGAR IS MOBILIZED FOR GLYCOSYLATION. SUGARS TAKEN UP FROM OUTSIDE T… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | LA JOLLA, CA-50 | 2024 | $5,921,080 |
ASST_NON_R01AG065541_075 ALTERED REVERSE TRANSCRIPTASE-DEPENDENT GENE DIVERSIFICATION MECHANISMS IN ALZHEIMER'S DISEASE BRAINS - PROJECT SUMMARY/ABSTRACT WE HAVE IDENTIFIED SOMATIC GENE RECOMBINATION (SGR… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | LA JOLLA, CA-50 | 2024 | $4,849,664 |
ASST_NON_R01AG062190_075 "A NOVEL ROLE FOR THE UPR COMPONENT, ATF6 IN AD-ASSOCIATED NEUROPROTECTIVE PATHWAYS" - PROJECT SUMMARY ALZHEIMER’S DISEASE (AD) IS THE MOST COMMON FORM OF DEMENTIA, CHARACTERIZED… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2025 | $4,833,528 |
ASST_NON_R01CA207189_075 REGULATION OF NUTRIENT STRESS-INDUCED MACROPINOCYTOSIS IN PANCREATIC DUCTAL ADENOCARCINOMA - PROJECT SUMMARY RECENT YEARS HAVE WITNESSED A GROWING APPRECIATION OF THE ROLE THAT ME… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $4,700,659 |
ASST_NON_P01CA281819_075 ROLE OF HYPERNUTRITION AND METABOLIC STRESS IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) DRIVEN HEPATOCELLULAR CARCINOMA (HCC) - PROJECT SUMMARY – OVERALL HEPATOCELLULAR CARCINOMA (HCC… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $4,700,110 |
ASST_NON_R01AG071465_075 TRANSFORMATIVE RESEARCH ON SOMATIC GENE RECOMBINATION IN THE NORMAL AND ALZHEIMER'S DISEASE-RELATED DEMENTIA BRAIN - PROJECT SUMMARY/ABSTRACT UNDERSTANDING THE HUMAN BRAIN AND ITS… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | LA JOLLA, CA-50 | 2024 | $4,622,570 |
ASST_NON_R01MH123826_075 A PHARMACOCHAPERONE-BASED STRATEGY FOR IDENTIFYING CHEMICAL PROBES OF BRAIN-DERIVED ORPHAN GPCRS - PROJECT SUMMARY NOWHERE IS THE NEED FOR DISEASE MODIFYING THERAPEUTIC COMPOUNDS… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | CA-90 | 2024 | $4,376,902 |
ASST_NON_R01AG071464_075 DEFINING CHROMOSTASIS - A CANDIDATE REGULATOR OF HEALTHY AGING AND LONGEVITY - PROJECT SUMMARY CHROMATIN IS A KEY DETERMINANT OF CELL PHENOTYPE AND FUNCTION. THEREFORE, CHROMATIN… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | CA-90 | 2024 | $3,857,028 |
ASST_NON_R01AI167977_075 COMPARATIVE RESISTOMICS OF GRAM-NEGATIVE BACTERIAL PATHOGENS - ABSTRACT INCREASING ANTIBIOTIC RESISTANCE NECESSITATES EXPANDING RESEARCH INTO THE MECHANISMS BY WHICH BACTERIAL PAT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,667,500 |
ASST_NON_R01AG071694_075 PRECLINICAL DISCOVERY OF NOVEL FARNESYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED TAUOPATHIES - PROJECT SUMMARY ALZHEIMER’S DISEASE (AD) IS A FAT… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2024 | $3,572,381 |
ASST_NON_R01AG061875_075 NOVEL ROLES FOR THE ALZHEIMER'S DISEASE (AD) RISK GENE, SORLA IN NEUROPROTECTION IN AD - PROJECT SUMMARY SORLA IS A GENETIC RISK FACTOR FOR ALZHEIMER’S DISEASE (AD) IDENTIFIED THR… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2024 | $3,409,595 |
ASST_NON_R01AG062557_075 TARGETING NEUROINFLAMMATION IN AD WITH NOVEL CX3CR1 AGONISTS - PROJECT SUMMARY FRACTALKINE PROTEIN (FKN, CX3CL1) SUPPRESSES MICROGLIAL ACTIVATION LEADING TO DECREASED NEURODEGENE… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2025 | $3,390,494 |
ASST_NON_R01GM131374_075 EPH RECEPTOR HETEROINTERACTIONS IN SIGNALING - SUMMARY RECEPTOR TYROSINE KINASES (RTKS) CAN INTERACT WITH OTHER MEMBERS OF THE SAME RTK FAMILY, FORMING HETEROCOMPLEXES WITH DISTIN… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | CA-90 | 2024 | $3,367,523 |
ASST_NON_R01AI124843_075 DEVELOPMENT OF SMAC MIMETICS AS LATENCY-REVERSING AGENTS - DESCRIPTION (PROVIDED BY APPLICANT): COMBINATION ANTIRETROVIRAL THERAPY FOR PATIENTS INFECTED WITH HIV CAN REDUCE V… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,366,672 |
ASST_NON_R01NS105969_075 BRAIN PATHOLOGY AND FUNCTION IN A CHRONIC MOUSE MODEL OF ZIKV TRANSMISSION - PROJECT SUMMARY ZIKA VIRUS (ZIKV) IS PRIMARILY TRANSMITTED TO PEOPLE THROUGH THE BITE OF AN INFECTED M… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | CA-90 | 2024 | $3,298,317 |
ASST_NON_R01AI148668_075 CHARACTERIZING THE NUCLEAR PORE COMPLEX-T CELL RECEPTOR CONNECTION - PROJECT SUMMARY NUCLEAR PORE COMPLEXES (NPCS) ARE LARGE MULTIPROTEIN CHANNELS THAT CONNECT THE NUCLEUS WITH TH… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2024 | $3,262,085 |
ASST_NON_R01AR077448_075 ROLE OF FBXW7-MEDIATED PROTEASOMAL DEGRADATION IN MYOFIBERS IN DETERMINING MUSCLE STEM CELL POOL SIZE - SUMMARY THE OVER-ARCHING GOAL OF THIS PROPOSAL IS TO DELINEATE THE SIGNALIN… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,146,257 |
ASST_NON_W81XWH2110642_097 SOMATIC GENE RECOMBINATION OF MAPT IN SINGLE CELLS F ROM FRONTOTEMPORAL LOBAR DEMENTIA (FTLD) BRAINS WITH TAU PATHOLOGY EXTEND THE PERIOD OF PERFORMANCE AND REMOVE PAYMENT RESTRIC… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | LA JOLLA, CA-50 | 2025 | $3,120,000 |
ASST_NON_R01AR078559_075 MECHANISMS THAT COUPLE IRREGULAR DEVELOPMENT OF FETAL MELANOBLASTS TO PREMATURE EXHAUSTION OF ADULT MELANOCYTE STEM CELLS - PROJECT SUMMARY MAINTENANCE OF TISSUE FUNCTION DURING A… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $3,102,648 |
ASST_NON_R01AI158552_075 OVERRIDING THE IMMUNE EVASION TACTICS OF CORONAVIRUS - PROJECT SUMMARY/ABSTRACT PROGRESSION OF SARS-CORONAVIRUS-2 (SARS-COV-2) INFECTED PATIENTS TO LIFE THREATENING DISEASE MAY RE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2024 | $3,034,585 |
ASST_NON_R01AG062617_075 DISCOVERY OF SELECTIVE INHIBITORS FOR THE EPHA4 KINASE - ALZHEIMER’S IS A DEVASTATING DISEASE INVOLVING CHRONIC, PROGRESSIVE NEURODEGENERATIVE PROCESSES AND DECLINE IN BRAIN COGNI… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2025 | $3,024,513 |
ASST_NON_RF1AG087011_075 FRAGMENT-BASED DISCOVERY OF STEP MODULATORS IN ALZHEIMER'S DISEASE ADMINISTRATIVE SUPPLEMENT - PROJECT SUMMARY STRIATAL-ENRICHED TYROSINE PHOSPHATASE (STEP) IS A NEURON-SPECIFIC P… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | LA JOLLA, CA-50 | 2024 | $2,947,358 |
ASST_NON_R01AG072468_075 MICROGLIAL HEPARAN SULFATE IN THE MODULATION OF APOE FUNCTION AND NEURODEGENERATION - HEPARAN SULFATE (HS), A SULFATED GLYCAN EXPRESSED AT THE CELL SURFACE AND IN EXTRACELLULAR MA… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | LA JOLLA, CA-50 | 2024 | $2,893,181 |
ASST_NON_R01CA254806_075 REGULATION AND FUNCTION OF STROMAL MACROPINOCYTOSIS IN PANCREATIC DUCTAL ADENOCARCINOMA - PROJECT SUMMARY RECENT YEARS HAVE WITNESSED AN APPRECIATION OF THE ROLE THAT METABOLIC AD… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $2,871,428 |
ASST_NON_RF1AG070391_075 ELUCIDATING A MICROGLIAASSOCIATED ROLE FOR SORLA IN MODULATING AD PATHOGENESIS - PROJECT SUMMARY MUTATIONS IN SORLA (ENCODED BY SORL1) IDENTIFIED THROUGH GWAS AND WHOLE EXOME SEQ… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2026 | $2,818,493 |
ASST_NON_R01DA056828_075 BRAIN-PENETRANT GPR88 AGONISTS AS NOVEL THERAPEUTICS FOR OPIOID ABUSE - SUMMARY SUBMITTED IN RESPONSE TO RFA-DA-22-031, THIS APPLICATION DESCRIBES A MULTIDISCIPLINARY EFFORT TO DE… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | CA-90 | 2024 | $2,795,026 |
ASST_NON_R56AG073965_075 NEW DOWN SYNDROME BRAIN ORGANIZATION REVEALED BY SINGLE-CELL GENOMICS - PROJECT SUMMARY/ABSTRACT NEARLY 100% OF DOWN SYNDROME (DS; TRISOMY OF HUMAN CHROMOSOME 21) INDIVIDUALS THAT… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2025 | $2,744,274 |
ASST_NON_R01AG065387_075 DEVELOPMENT OF STEP ALLOSTERIC INHIBITORS AS NOVEL THERAPEUTICS FOR ALZHEIMER'S DISEASE - PROJECT SUMMARY STRIATAL-ENRICHED TYROSINE PHOSPHATASE (STEP) IS A NEURON-SPECIFIC PROTEI… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | LA JOLLA, CA-50 | 2024 | $2,712,313 |
ASST_NON_R01CA266973_075 GCDH ADDICTION IN MELANOMA - PROJECT SUMMARY IN THIS REVISED R01 APPLICATION WE PROPOSE TO CHARACTERIZE A NOVEL MECHANISM UNDERLYING THE CONTROL OF APOPTOSIS BY THE MITOCHONDRIAL… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LOS ANGELES, CA-30 | 2024 | $2,601,783 |
ASST_NON_R01AG085498_075 NOVEL NEUROPROTECTIVE ROLES FOR THE ALZHEIMER'S DISEASE RISK GENE SORLA IN TAU PATHOLOGY AND PATHOGENESIS - NUMEROUS MUTATIONAL VARIANTS IN THE SORLA (SORL1) GENE ARE ASSOCIATED W… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | LA JOLLA, CA-50 | 2024 | $2,591,660 |
ASST_NON_R01CA276193_075 DISCOVERY OF NOVEL INHIBITORS TARGETING TRANS-GOLGI NETWORK ACIDIFICATION IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS PROJECTED TO BE THE SE… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | LA JOLLA, CA-50 | 2024 | $2,551,094 |
ASST_NON_R01AA030888_075 OPTIMIZATION OF DRUG-LIKE PROPERTIES OF CRFBP-CRF2 NEGATIVE ALLOSTERIC MODULATORS FOR ALCOHOL USE DISORDER - PROJECT SUMMARY THIS APPLICATION, “OPTIMIZATION OF DRUG-LIKE PROPERTIE… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | LA JOLLA, CA-50 | 2024 | $2,438,146 |
ASST_NON_R01HL141880_075 MECHANISMS OF HEMATOPOIETIC ACUTE RADIATION SYNDROME INDUCTION AND RADIOPROTECTION THROUGH SPHINGOSINE 1-PHOSPHATE RECEPTOR 1 SIGNAL MODULATION - SIGNIFICANCE: IONIZING RADIATION… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $2,433,111 |
ASST_NON_R01AA026589_075 LEAD OPTIMIZATION OF NOVEL CRFBP-CRFR2 COMPLEX MODULATORS FOR ALCOHOL USE DISORDER - PROJECT SUMMARY THIS R01 APPLICATION ENTITLED “LEAD OPTIMIZATION OF NOVEL CRFBP-CRFR2 COMPLEX… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | LA JOLLA, CA-50 | 2024 | $2,429,337 |
ASST_NON_R01AI151371_075 PROTEIN SIALYLATION AND DE-SIALYATION IN CELL SURFACE GLYCOPROTEIN HOMEOSTASIS AND DISEASE - SUMMARY PROTEIN SIALYLATION IS A POST-TRANSLATIONAL MODIFICATION PRODUCED BY MEMBERS O… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | LA JOLLA, CA-50 | 2024 | $2,422,875 |
ASST_NON_R01CA262794_075 EPHA2 RECEPTOR SIGNALING IN BREAST CANCER MECHANOTRANSDUCTION - SUMMARY MECHANICAL FORCES GENERATED BY A RIGID EXTRACELLULAR MATRIX (ECM) IN THE TUMOR MICROENVIRONMENT PLAY A KEY… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | LA JOLLA, CA-50 | 2024 | $2,315,344 |
ASST_NON_R01DK132689_075 IMPROVING PROINSULIN FOLDING TO AMELIORATE TYPE II DIABETES - PROJECT SUMMARY DIABETES IS AMONG THE FASTEST GROWING HEALTH CHALLENGES OF THE 21ST CENTURY, AFFECTING >30 MILLION PE… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | LA JOLLA, CA-50 | 2024 | $2,300,175 |
ASST_NON_R01CA266828_075 DISCOVERY OF GLUTARYL-COA DEHYDROGENASE INHIBITORS FOR MELANOMA AND PANCREATIC CANCER - PROJECT SUMMARY MELANOMA IS AN EXTREMELY AGGRESSIVE CANCER WITH HIGH MORTALITY. ITS PHENOTY… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | CA-90 | 2024 | $2,285,106 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.397 — CANCER CENTERS SUPPORT GRANTS$73.2M
93.866 — AGING RESEARCH$66.0M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$47.4M
93.279 — DRUG USE AND ADDICTION RESEARCH PROGRAMS$36.1M
93.396 — CANCER BIOLOGY RESEARCH$33.5M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$24.0M
93.310 — TRANS-NIH RESEARCH SUPPORT$19.3M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$16.9M
93.846 — ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH$15.6M
93.395 — CANCER TREATMENT RESEARCH$14.9M
Source: USAspending.gov · All Recipients · California